We estimate that total OPPS payments for CY 2026, including beneficiary cost-sharing, to the approximately 3,600 facilities paid under the OPPS (including general acute care hospitals, children's hospitals, cancer hospitals, and CMHCs) will increase by approximately $1.77 billion compared to CY 2025 payments due to the OPD update, excluding changes in enrollment, utilization, and case-mix
These shots are formulated with a high concentration of methylcobalamin, which is recognized as the most active and bioavailable form of vitamin B12
2), is the average fluid/cell velocity (since the fluid moves at the same speed as the cell), A is the cross-sectional area and R is the hydraulic resistance (i.e., the external load that resists cell/fluid movement) which, for rectangular channels, is proportional to the channel length L
Even determining which form of the peptides should be used was unclear to regulators, since substances like TB-500 aren't recognized as official pharmaceutical ingredients in the U.S
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
